parkinson's disease Genetic Breakthrough Promises Personalized Treatment Within Five Years, Experts Say
San Francisco, CA – In a landmark development set to reshape neurology, researchers at Stanford University announced today that a new AI-driven analysis of 10,000 genomes has identified six distinct subtypes of parkinson's disease, each with a unique molecular signature. The discovery, published in *Nature Medicine*, is predicted to enable targeted therapies tailored to individual patients within the next decade. "This is the end of one-size-fits-all treatment for parkinson's disease," said lead researcher Dr. Elena Vance. The team predicts that by 2035, early-diagnosis blood tests and personalized gene-editing drugs could slow or halt disease progression, cutting the number of new cases by 40%. The announcement sparked a 300% spike in biotech stock trading and global calls for accelerated clinical trials.